Back
Novo Nordisk A/S Vs. Revolution Medicines, Inc. Industry Stock Comparison
Sell
48
NVO
Novo Nordisk A/S
Last Price:
$59.15
Seasonality Move:
5.97%
Buy
64
RVMD
Revolution Medicines, Inc.
Last Price:
$118.75
Seasonality Move:
-1.63%
Sell
48
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $57.34. The Score for NVO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Revolution Medicines, Inc. (RVMD)
is a Buy
Is Revolution Medicines, Inc. a Buy, Sell or Hold?
-
The current Revolution Medicines, Inc. [RVMD] share price is $107.39. The Score for RVMD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RVMD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $57.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing slight selling pressure.
RVMD Stock Price Chart
What is Revolution Medicines, Inc.'s stock price today?
-
The Revolution Medicines, Inc. share price today is $107.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVMD is experiencing slight buying pressure.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 72.6 | Buy |
| Chaikin Money Flow: | -4665319 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.51 - 53.67) | Buy |
| Bollinger Bands (100): | (48.72 - 57.26) | Buy |
RVMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.48 | Buy |
| Relative Strength Index (14 RSI): | 88.38 | Buy |
| Chaikin Money Flow: | 5950544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.87 - 88.29) | Buy |
| Bollinger Bands (100): | (42.5 - 75.96) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.91 | Buy |
| 20-day SMA: | 51.41 | Buy |
| 50-day SMA: | 49.49 | Buy |
| 200-day SMA: | 59.34 | Sell |
| 8-day EMA: | 54.56 | Buy |
| 20-day EMA: | 52.2 | Buy |
| 50-day EMA: | 51.4 | Buy |
| 200-day EMA: | 61.96 | Sell |
RVMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.89 | Buy |
| 20-day SMA: | 81.66 | Buy |
| 50-day SMA: | 73.85 | Buy |
| 200-day SMA: | 48.59 | Buy |
| 8-day EMA: | 89.67 | Buy |
| 20-day EMA: | 83.17 | Buy |
| 50-day EMA: | 74.2 | Buy |
| 200-day EMA: | 54.94 | Buy |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.46 per share.
Revolution Medicines, Inc. Earnings Growth & RVMD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and an increase next year of $0.59 per share.
Novo Nordisk A/S Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revolution Medicines, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||